Mishawaka Medicaid providers report $383,049 in 2024 COVID-19 billings

In 2024, Medicaid payments in Mishawaka reached no less than $383,049 for services billed with HCPCS codes designated for COVID-19, based on data from the U.S. Department of Health and Human Services Medicaid Provider Spending database.

Medicaid is a statewide public insurance plan funded in partnership by state and federal governments. Serving low-income populations, seniors, children, and people with disabilities, Medicaid remains a foundational element of the U.S. health system.

Since Medicaid is publicly funded, fluctuations in billing volumes offer a window into community health spending allocation.

Researchers identified COVID-19–related Medicaid services for this analysis using HCPCS codes labeled or classified with “COVID-19” or “coronavirus” in either their billing descriptions or associated reference data. Therefore, only services explicitly designated as COVID-related in the claims data are included, excluding those pandemic treatments billed under other or broader categorizations.

Hammond led cities in Indiana for the highest COVID-19–related Medicaid payments in 2024, posting $443,500 in claims tied to the virus for the year.

Four Mishawaka providers submitted claims for COVID-19–specified services through Medicaid in 2024. The code COVID Specific made up the largest portion, with $236,740 billed.

The average per-provider Medicaid payment for COVID-19–linked services in Mishawaka settled at $95,762, exceeding the state’s average of $17,610 for such services.

Medicaid spending in Mishawaka saw notable increases for COVID-19–labeled care during the active pandemic years.

Across all claim types aside from COVID-19–related, Mishawaka Medicaid payments increased by $6,239,896 from 2020 to 2024—a rise of 38.4%.

Before the pandemic, Mishawaka averaged $12,382,689 in Medicaid payments per year over the two previous years.

According to the Centers for Medicare & Medicaid Services, federal and state Medicaid disbursements totaled approximately $871.7 billion in fiscal 2023, making up around 18% of U.S. health expenditures—a considerable increase from about $613.5 billion in 2019, before the onset of COVID-19.

This jump of about 40% in just a few years was spurred in large part by expanded eligibility and greater service utilization surrounding the pandemic period.

Recent federal budget bills passed during the Trump administration introduced far-reaching changes to Medicaid funding. The “One Big Beautiful Bill Act,” enacted in 2025, is expected to reduce federal Medicaid spending by more than $1 trillion over 10 years and implement changes including work requirements and increased beneficiary cost-sharing, potentially decreasing coverage for some groups. These reforms would likely shift financial responsibility to states and slow federal Medicaid growth, while the program remains critical for millions of Americans.

Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.

This article draws upon information from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The original source can be found here.